Alzheimers Disease and other Cognitive Disorders
Resources
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Life Span After Alzheimer's Diagnosis: What Factors Matter MostLots of Napping Could Raise a Senior's Odds for Alzheimer'sIs It 'Pre-Alzheimer's' or Normal Aging? Poll Finds Many Americans UnclearMore Evidence That Education May Protect Against DementiaAHA News: These Three Risk Factors May Have the Biggest Impact on Dementia CasesAHA News: Traumatic Brain Injury May Raise Veterans' Long-Term Stroke RiskMore Years Playing Hockey, Higher Odds for CTE Linked to Head InjuryEarly Menopause May Raise a Woman's Odds for DementiaPandemic Caused Rise in Deaths of Alzheimer's PatientsStaying Fit May Keep Alzheimer's at BayConcussion's Impact on Memory, Thinking May Linger More Than a YearBrain Injuries May Be Driving Higher Death Rate for U.S. VeteransHints That Viagra-Like Drugs Might Help Prevent DementiaAHA News: Statistics Report Offers Snapshot of the Nation's Brain Health – And a Guide to Protecting ItKeeping Weight Stable Could Help Save Your BrainMedicare Proposes to Only Cover Alzheimer's Drug Aduhelm for Use in Clinical TrialsAduhelm: Will Medicare Cover the Controversial Alzheimer's Drug?More U.S. Seniors, Especially Women, Are Retaining Healthy Brains: StudyMaker Cuts Price of Controversial New Alzheimer's Drug in HalfCertain Meds Raise Odds for Delirium After SurgeryCould Viagra Help Prevent Alzheimer's?Clearing Out Clutter Might Not Help People With DementiaLifetime Spent With Epilepsy Ages the Brain, Study Finds'Mild Cognitive Impairment' in Older Age Often Disappears, Study FindsMore Years Playing Football, More Brain Lesions on MRI: StudyReminder Apps on Smartphones May Help in Early DementiaNeurologists' Group Issues Guidance to Families on Controversial Alzheimer's DrugTrial Begins of Nasal Vaccine for Alzheimer's DiseaseAlzheimer's Diagnosis May Come With Big Cost to Social LifeCould Estrogen Help Shield Women's Brains From Alzheimer's?Purrfect Pal: Robotic Cats May Help People With DementiaRight Amount of Sleep May Be Important in Early Alzheimer'sAHA News: Hearing Loss and the Link to DementiaDepression in Early Life May Up Dementia Risk LaterScientists Untangle Why Diabetes Might Raise Alzheimer's RiskTracking Key Protein Helps Predict Outcomes in TBI PatientsMIND Diet May Guard Against Alzheimer'sSigns of Early Alzheimer's May Be Spotted in Brain StemCould Cholesterol Help Drive Alzheimer's Disease?Most Alzheimer's Patients Wouldn't Have Qualified for Controversial Drug's Trial: StudyAHA News: What Are Researchers Doing to Stop Dementia?A Mentally Challenging Job Could Help Ward Off DementiaDirty Air, Higher Dementia Risk?An ALS Drug Shows Early Promise Against Alzheimer'sAHA News: Dementia Can Complicate Heart Recovery and TreatmentDeaths From Alzheimer's Far More Common in Rural AmericaCould COVID-19 Accelerate Alzheimer's Symptoms?Dementia Cases Will Nearly Triple Worldwide by 2050: StudyFDA Panel Advisor Who Panned New Alzheimer's Drug Speaks Out'Light Flash' Treatment Might Help Slow Alzheimer's
Questions and AnswersVideosLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

Trial Begins of Nasal Vaccine for Alzheimer's Disease

HealthDay News
by Robert Preidt
Updated: Nov 17th 2021

new article illustration

WEDNESDAY, Nov. 17, 2021 (HealthDay News) -- The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.

This is a "remarkable milestone," according to Dr. Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital in Boston.

"Over the last two decades, we've amassed preclinical evidence suggesting the potential of this nasal vaccine for AD [Alzheimer's disease]," Weiner said in a hospital news release. "If clinical trials in humans show that the vaccine is safe and effective, this could represent a nontoxic treatment for people with Alzheimer's, and it could also be given early to help prevent Alzheimer's in people at risk."

The vaccine features an experimental agent called Protollin that stimulates the immune system. It's designed to prompt white blood cells in the lymph nodes on the sides and back of the neck to migrate to the brain and clear beta amyloid plaques, a hallmark of Alzheimer's disease.

According to Dr. Tanuja Chitnis, principal investigator in the trial, "For 20 years, there has been growing evidence that the immune system plays a key role in eliminating beta amyloid. This vaccine harnesses a novel arm of the immune system to treat AD." Chitnis is a professor of neurology at the hospital.

"Research in this area has paved the way for us to pursue a whole new avenue for potentially treating not only AD, but also other neurodegenerative diseases," she added.

The phase 1 trial will include 16 patients between 60 and 85 years of age who have early, symptomatic Alzheimer's disease but are otherwise in good general health. They will receive two doses of the nasal vaccine one week apart.

Along with assessing the vaccine's safety and how well patients tolerate it, the researchers will examine how it affects immune response, including its impact on white blood cells.

The trial is funded by I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical, developers and makers of Protollin.

More information

The Alzheimer's Association has more on Alzheimer's disease.

SOURCE: Brigham and Women's Hospital, news release, Nov. 16, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net